Business ❯ Pharmaceuticals ❯ Drug Development

Oncology

Clinical Trials Precision Medicine Checkpoint Therapeutics KRAS G12D Inhibitors HER2-positive Cancer Therapies Partnerships Collaboration Agreements Acute Myeloid Leukemia Lung Cancer Chronic Lymphocytic Leukaemia KRAS Inhibitors ISB 2001 Prostate Cancer

AstraZeneca Licenses Global Rights to Zegfrovy From Dizal

The deal gives AstraZeneca the commercial scale to broaden access to the EGFR exon 20 insertion drug while first-line approval reviews continue.

Roche and Nurix Strike $700M Deal to Co‑Develop Oral BTK Degrader Bexobrutideg

Pfizer and Innovent Strike Up to $10.5 Billion Oncology Collaboration

Bristol Myers and Hengrui Ink Up to $15.2 Billion Drug Discovery Alliance

Astellas–Vir Prostate Cancer Alliance Launches With New Data as VIR Stock Surges